Alzheimer’s Disease Against A Cancer – Part 2 of 3
The 2012 study suggested that bexarotene was able to at the speed of light reverse the build-up of beta amyloid plaques in the brains of mice. The authors of the initial study concluded that treatment with the drug might reverse the cognitive and memory problems associated with the improvement of Alzheimer’s. Sangram Sisodia, a professor of neurosciences at the University of Chicago and a study co-author of the latest research, admitted being skeptical about the initial findings.
“We were surprised and excited – even stunned – when we primary saw these results presented at a small conference,” Sisodia said in a University of Chicago Medical Center news release. “The mechanism of action made some sense, but the declaration that they could reduce the areas of plaque by 50 percent within three days and by 75 percent in two weeks seemed too good to be true”.